Congratulations are in order to our firm's client BreathID on their completion of their IPO!

The Eitan-Mehulal Law Group is proud to say that it manages the patent portfolio, drafting, prosecution and IP strategy for BreathID.

BreatID's mission is to redefine point-of-care diagnostics of gastrointestinal and liver diseases. It is currently engaged in the development and commercialization of a revolutionary point-of-care, breath-testing system, the BreathID System, which enables gastroenterologists and hepotologists to diagnose and manage a wide range of diseases and disorders of the digestive system with continuous, real-time, automatic breath collection and analysis.